These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3830067)

  • 1. A case of normocalcemic primary hyperparathyroidism with osteomalacia.
    Shimada I; Inaba M; Nakano H; Miki T; Nishizawa Y; Morii H
    Endocrinol Jpn; 1986 Oct; 33(5):575-82. PubMed ID: 3830067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia.
    Takemia T; Sato K; Miyata M; Imaki T; Shibasaki T; Tsushima T; Demura H; Tanaka R; Obara T; Oguchi S
    Endocr J; 1993 Feb; 40(1):121-6. PubMed ID: 7951485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocalcemia due to spontaneous infarction of parathyroid adenoma and osteomalacia in a patient with primary hyperparathyroidism.
    Otsuka F; Ogura T; Sato T; Hayakawa N; Mimura Y; Kishida M; Yamauchi T; Makino H
    Endocr J; 1998 Oct; 45(5):617-23. PubMed ID: 10395241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperparathyroidism after removal of a parathyroid adenoma.
    Jiménez-Montero JG; Lobo-Hernández E; Picado-Larios A; Molina MA
    Endocr Pract; 2002; 8(6):429-32. PubMed ID: 15260008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-related osteomalacia followed after treatment by hyperparathyroidism.
    Heylen A; Dasnoy D; Hustin J; Pochet JM
    Rev Rhum Engl Ed; 1999 Jan; 66(1):53-7. PubMed ID: 10036701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteomalacia secondary to celiac disease, primary hyperparathyroidism, and Graves' disease.
    Gannage MH; Abikaram G; Nasr F; Awada H
    Am J Med Sci; 1998 Feb; 315(2):136-9. PubMed ID: 9472914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis.
    Weinstein RS; Harris RL
    Calcif Tissue Int; 1990 Jun; 46(6):361-6. PubMed ID: 2114209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18-year-old patient with hypercalcemia, hypophosphatemia, nephrocalcinosis and normal iPTH values. Primary hyperparathyroidism].
    Baumgart DC; Ventz M; Wermke W
    Internist (Berl); 1998 Apr; 39(4):403-8. PubMed ID: 9599752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
    Huang QL; Feig DS; Blackstein ME
    J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteomalacia as a very late manifestation of primary hyperparathyroidism.
    Kaplan FS; Soffer SR; Fallon MD; Haddad JG; Dalinka M; Raffensperger EC
    Clin Orthop Relat Res; 1988 Mar; (228):26-32. PubMed ID: 3342577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ionized calcium and parathyroid hormone in renal stone disease.
    Muldowney FP; Freaney R; McMullin JP; Towers RP; Spillane A; O'Connor P; O'Donohoe P; Moloney M
    Q J Med; 1976 Jan; 45(177):75-86. PubMed ID: 1257401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperparathyroidism masked by osteomalacia. Is vitamin D administration in every case of osteomalacia problem-free?].
    Zuber M; Löliger M; Boner H; Haas HG
    Schweiz Med Wochenschr; 1986 May; 116(19):642-7. PubMed ID: 3715442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic primary hyperparathyroidism with fractures.
    Wu PH; Wang CJ
    J Arthroplasty; 2002 Sep; 17(6):805-9. PubMed ID: 12216040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
    Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
    Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperparathyroidism presenting as anticonvulsant-induced osteomalacia.
    Broadus AE; Hanson TA; Bartter FC; Walton J
    Am J Med; 1977 Aug; 63(2):298-305. PubMed ID: 196503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATYPICAL PRIMARY HYPERPARATHYROIDISM DUE TO HYPOVITAMINOSIS D.
    Gaţu AA; Velicescu C; Novac R; Mogoş V; Brănişteanu DD
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):384-9. PubMed ID: 26204641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D status in primary hyperparathyroidism in India.
    Harinarayan CV; Gupta N; Kochupillai N
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):351-8. PubMed ID: 7586606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual variants of hyperparathyroidism.
    McLaren EH; Epstein S; Millner G
    S Afr Med J; 1973 Apr; 47(14):611-5. PubMed ID: 4701298
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
    Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
    J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.